Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.

Clinical trial NCT01193257 · COMPLETED

Trial details

NCT number: NCT01193257
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2010-11-15
Primary completion: 2013-05-16
Enrollment: 1099

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.